Jupiter Neurosciences Statistics
Total Valuation
JUNS has a market cap or net worth of $44.24 million. The enterprise value is $41.86 million.
Market Cap | 44.24M |
Enterprise Value | 41.86M |
Important Dates
The last earnings date was Tuesday, August 19, 2025, before market open.
Earnings Date | Aug 19, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
JUNS has 34.83 million shares outstanding. The number of shares has increased by 18.72% in one year.
Current Share Class | 34.83M |
Shares Outstanding | 34.83M |
Shares Change (YoY) | +18.72% |
Shares Change (QoQ) | +0.23% |
Owned by Insiders (%) | 53.47% |
Owned by Institutions (%) | 0.21% |
Float | 16.21M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 64.39 |
PB Ratio | 32.49 |
P/TBV Ratio | 32.49 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 0.14.
Current Ratio | 1.07 |
Quick Ratio | 0.71 |
Debt / Equity | 0.14 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -44.81 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -175.60% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -430.29% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.48M |
Employee Count | 4 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 1.50 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 43.39 |
Average Volume (20 Days) | 170,420 |
Short Selling Information
The latest short interest is 204,300, so 0.59% of the outstanding shares have been sold short.
Short Interest | 204,300 |
Short Previous Month | 43,212 |
Short % of Shares Out | 0.59% |
Short % of Float | 1.26% |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | -1.52M |
Operating Income | -5.77M |
Pretax Income | n/a |
Net Income | -5.90M |
EBITDA | n/a |
EBIT | -5.77M |
Earnings Per Share (EPS) | -$0.19 |
Balance Sheet
The company has $1.88 million in cash and $192,860 in debt, giving a net cash position of $1.69 million or $0.05 per share.
Cash & Cash Equivalents | 1.88M |
Total Debt | 192,860 |
Net Cash | 1.69M |
Net Cash Per Share | $0.05 |
Equity (Book Value) | 1.34M |
Book Value Per Share | 0.04 |
Working Capital | 191,147 |
Cash Flow
Operating Cash Flow | -5.63M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
JUNS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -18.72% |
Shareholder Yield | -18.72% |
Earnings Yield | -13.55% |
FCF Yield | n/a |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |